Medlive, a company focused on empowering clinicians, patients, and caregivers through digital education, is proud to announce the acceptance of two abstracts, for presentation at the AAN 2025 Annual Meeting taking place April 5 – 9, in San Diego. During the event, our expert medical team will highlight our findings, showcasing innovative data and insights gained through our collaborative educational initiatives. […]
Historically, patients with HER2-positive metastatic colorectal cancer (mCRC) have had few options for treatment if their condition had progressed following frontline therapy. Recently, novel targeted therapies have entered the treatment landscape for these patients – providing hope for improved patient outcomes. Due to these innovations, an educational need emerged to ensure that these therapies are used effectively in clinical practice. […]
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic condition where growths called polyps form in the nose and sinuses, often due to underlying type 2 inflammation. CRSwNP can cause severe congestion, facial pain and pressure, and loss of smell, impairing quality of life and making daily tasks more difficult. For years, surgery was the main treatment for CRSwNP, and many patients still benefit from it. But polyps return and before the advent of biologics, treatment choices were limited. Today, biologics offer a targeted approach by addressing the underlying inflammation. They can reduce polyp size and improve sense of smell. However, many clinicians and patients remain unfamiliar with these treatments, underscoring the need for education. […]
Medlive, a company focused on empowering clinicians, patients, and caregivers through digital education, is proud to announce that two abstracts have been accepted for presentation at the 66th ASH® Annual Meeting and Exposition taking place December 7 – 10, 2024 in San Diego. […]
The treatment of Rett Syndrome (RTT), a rare, genetic neurological disorder affecting young children that leads to severe impairments, is continuing to evolve. The first therapy was approved in March 2023, and with several investigational assets on the horizon, there is a critical need to educate both community-based clinicians and Centers of Excellence on this change to the standard of care. […]
Asthma, a serious chronic lung disease, affects 26.8 million adults and 4.5 million children in the U.S. according to the American Lung Association.1 Research on the pathophysiology of type 2 inflammation has brought new targeted therapies to market that may make a significant difference for patients affected by uncontrolled moderate-to-severe asthma.2 While these innovative biologics play a significant role in treating disease, integration by healthcare practitioners (HCPs) remains inconsistent due to barriers in provider knowledge and confidence. […]
Triple-negative breast cancer (TNBC) remains difficult to treat, and disproportionately affects women of color. To address these challenges, PlatformQ Health joined together with TOUCH: The Black Breast Cancer Alliance and the National Breast Cancer Foundation to develop a tethered educational program to empower patients in treatment decision making and to help facilitate better patient-clinical communication through sharing of real-world outcomes. […]
Early treatment of homozygous familial hypercholesterolemia (HoFH) improves outcomes for children and reduces the risk of progressive atherosclerotic cardiovascular disease. Unfortunately, the disease often goes undetected until it is in the advanced stages. […]
For people with moderate-to-severe asthma, personalization of biologic agents is warranted based on factors such as biomarkers and comorbidities. PlatformQ Health and the Asthma and Allergy Foundation of America (AAFA) conducted a CME-certified, case based, expert panel discussion that featured a live Q&A session with leading faculty from the Asthma Center at Cincinnati Children’s Hospital Medical Center and the Division of Allergy and Immunology at Northwestern University’s Feinberg School of Medicine, as well as AAFA’s public health manager. […]
PlatformQ Health is known for its outcomes-driven education. At this year’s European Conference on Rare Diseases, we co-presented two posters highlighting outcomes and lessons learned from recent programming. […]
The first FDA-approved gene therapy for pediatric patients with Duchenne muscular dystrophy (DMD) is now available. This is a genetic disorder that presents as progressive muscle degeneration and weakness. […]
PlatformQ Health, the National Organization for Rare Disorders (NORD), the International Fibrodyslpasia Ossificans Progressiva Association (IFOPA) […]
Clinical trials are crucial for advancing care for non-Hodgkin’s lymphoma (NHL), however, accrual in these studies remains low. To address this issue, PlatformQ Health, the Leukemia & Lymphoma Society, BlackDoctor.org, and Partners for Advancing Clinical Education co-produced the BUILD-NHL Trial Equity Initiative. […]
PlatformQ Health, the Asthma and Allergy Foundation of America (AAFA), and BlackDoctor.org were seeking to understand whether aligned (sequential patient/provider) education could help improve health equity for those suffering from conditions such as asthma and atopic dermatitis. […]
Immunotherapy is increasingly being used to treat patients with melanoma and other types of cancer. Management of these therapies differs distinctly from previous standard-of-care options such as chemotherapy. Optimizing care involves educating a multidisciplinary healthcare team about therapy management as well as educating patients about therapies and the factors that can influence outcomes. […]
In the wake of FDA approvals for treating myasthenia gravis (gMG, healthcare providers have the ability to individualize treatment. As these new therapies become adopted, it’s crucial to educate patients and providers about issues such as disease presentation, comorbidities, and patient preferences that may impact treatment decisions. […]
PlatformQ Health is excited to share that our poster session “Incorporating the Patient Voice in Rare Disease Education: Multi Stakeholder Collaborations to Improve Diagnosis, Quality of Care, and Outcomes” was selected to be presented both at the 2023 NORD Breakthrough Summit and at the Lighting Round Poster Presentations taking place from 4:30-5:00 PM on Monday, October 16. […]
Numerous posters of educational outcomes have been published at major conferences over the past three years across neuromuscular conditions, including Duchenne muscular dystrophy (DMD), myasthenia gravis (mGM), and spinal muscular atrophy (SMA). These posters highlight the advantages of aligned patient/provider education for closing knowledge gaps and aligning expectations between patients and providers. […]
Data collected before and after continuing medical education on the management of familial hypercholesterolemia (HoFH) showed that provider knowledge and competence was notable improved after the session. A poster session presented at the 2023 National Lipid Association Scientific Sessions demonstrated that CME that included patient voice enhanced the ability of providers to adapt to the changing HoFH treatment landscape. […]
There is a high burden of multiple sclerosis (MS) in the Black, Asian, and Hispanic communities, yet clinicians are often not prepared to care for diverse populations of patients. To address this issue, PlatformQ Health and the Consortium of Multiple Sclerosis Centers partnered to develop CME activities, including a 60-minute lecture and 75-minutes of case-based […]
With the growth of biologic agents to treat severe asthma, there is an increased need for shared decision-making between patients and healthcare providers. A poster recently accepted to the 2023 American Thoracic Society conference highlights the value of tethered education (otherwise called aligned education) for this purpose. This involves having a patient program, followed soon after by a provider program where we share insights from the patient program with providers. […]
Racial and ethnic disparities in clinical research leave many patients at a disadvantage, with lack of access to emerging therapies and lack of assurance that newly approved medications will be safe and effective for them. […]
Education about rare diseases is crucial to reducing time to diagnosis and providing optimal care for patients. Recently, PlatformQ Health worked with our strategic partner the National Organization for Rare Disorders (NORD) to produce digital education for health care providers (HCPs), focused on the rare dermatological condition prurigo nodularis. The 60-minute continuing medication education (CME) […]
The digital education firm PlatformQ Health had two posters accepted at the 2023 American Academy of Neurology Annual Meeting, held in Boston from April 22-27, 2023. The company regularly shares outcomes from its health care provider (HCP) and patient-focused educational programs. During the annual meeting, PlatformQ Health’s posters focused on the results of recent HCP educational programs focused on Rett syndrome and Alzheimer’s disease. […]
PlatformQ Health had 20 posters accepted at major medical and healthcare conferences during 2022. We’re pleased to share the posters, highlighting key outcomes from our educational initiatives across an array of therapeutic areas. Oncology 2022 Alliance Industry Summit Supplemental Digital Resources CME Program Closes Critical Knowledge Gap in Cancer Immunotherapy Treatment Presenting Education Outcomes at […]
Patients with chronic spontaneous urticaria (CSU) often suffer with unresolved symptoms, despite numerous visits to different healthcare providers. In a recent poster presented at the 2023 American Academy of Allergy, Asthma, and Immunology, PlatformQ Health evaluated the impact of digital continuing medical education (CME) on optimizing diagnosis as well as antihistamine dosing. […]
Gastric or gastroesophageal junction (GEJ) adenocarcinomas are notoriously difficult to treat, but recently approved immune checkpoint inhibitors and HER2-directed antibody drug conjugates are improving outcomes for patients with these conditions. While these advances are a positive change, they do pose challenges for healthcare providers who need to learn about new regimens and practices. […]
Vast racial disparities exist in triple-negative breast cancer (TNBC), yet many patients and providers are aware of these issues. Women of the African Diaspora (WAD) are often diagnosed at a more advanced stage and experience higher rates of TNBC-related mortality. Though the TNBC treatment landscape has changed with the influx of new clinical data and newly approved treatments, there is much education needed to ensure patients and the medical community are aware of these advances. […]
Targeted treatment regimens have significantly improved overall survival for patients with chronic lymphocytic leukemia (CLL). The emergence of new options such as BTK inhibitors has shifted the treatment landscape significantly, bringing a pressing need for education for providers, patients, and caregivers. […]
The growth of immunotherapies has shifted the standard of care for treating many solid tumors. As new indications are approved, there is a growing need for clinician education in this space. […]
Early diagnosis and treatment of homozygous familial hypercholesterolemia (HoFH) are key to reducing patients’ risk, yet there is low awareness of current guidelines and treatment options among healthcare practitioners. […]
Targeted therapies have allowed for better management of neuroendocrine tumors (NETs), yet this requires that healthcare providers glean new knowledge about treatment options such as somatostatin analogs. To improve provider competency and include consideration of patient perspectives in treatment selection, PlatformQ Health and Healing NET Foundation teamed up with the Moffitt Cancer Center to produce a free educational initiative for providers. […]
Patients often face an epic journey of many years before receiving a diagnosis for a rare disease. With nearly one in 10 Americans impacted by a rare condition, it is essential that we decrease the time to diagnosis to improve the lives of these individuals and their families. […]
PlatformQ Health presents a poster at the 2022 ASCO Quality Care Symposium on educational outcomes in Urothelial Carcinoma. […]
Educational outcomes from “Evolving Treatment Approaches for Generalized Myasthenia Gravis to Reduce Disease Burden and Improve Daily Living” accepted at the MGFA Scientific Session at the 2022 AANEM Conference. […]
Primary mitochondrial disease (PMD) is often missed by clinicians due to the broad range of clinical presentations and genetic etiologies. Our recent program “Progressive Myopathy: Could it be a Genetic Mitochondrial Disease?” focused on diagnosing this condition in infants, children, and adults who present with progressive muscle weakness; understanding the diagnostic workup; and manifestations of thymidine kinase 2 (TK2) deficiency. […]
The 2022 ASCO Annual Meeting is a place where cutting-edge research spanning all major disease sites comes together so leaders in the field can stay up-to-date on clinical trials, the latest findings, and global perspectives on oncology innovations. We are especially excited to have two accepted e-abstracts at the 2022 ASCO Annual Meeting that demonstrate the […]
Carole Drexel, PhD, Medical Director & Vice President of Patient Education will present a poster at the 2022 ASGCT Annual Meeting at 5:30PM in Hall D, demonstrating the ability of digital education to improve healthcare provider (HCP) competency when preparing for a change in care delivery. […]
The initiative succeeded in improving clinicians’ understanding of topics such as biomarker testing, combination therapies, checkpoint inhibitor use, adverse event management, and more. […]
Poster Presentation The Power of Education to Debunk Myths and Misconceptions about Clinical Trial Participation Among People with Diverse Racial and Ethnic Backgrounds The 2022 Alliance Industry Summit (ASI) will feature our poster about the power of education to debunk myths and misconceptions about clinical trial participation among people from diverse racial and ethnic backgrounds. […]
PlatformQ Health is proud to be presenting three posters in Migraine, SMA and Insomnia at the American Academy of Neurology’s Annual 2022 Meeting. […]
After the CME session, 74 percent of learners reported that the activity positively impacted their clinical practice while 61 percent of learners reported that the activity positively impacted patient experiences and outcomes. […]
Through tethered education PlatformQ Health sought to address educational gaps around understanding treatment options, side effects, side of disability progression, and strategies to manage functional losses. […]
PlatformQ Health teamed up with Advances in Neuroblastoma Research Association and Solving Kids’ Cancer to develop two one-hour CME programs for clinicians, patients, and caregivers. […]
For many people suffering from rare diseases, the diagnostic odyssey is far too long. Nearly 1 in 13 people are living with an undiagnosed condition, and it typically takes five years or longer to receive the correct diagnosis. Consistent clinician and patient education about rare diseases is crucial for helping to reduce time to diagnosis […]
PlatformQ Health regularly tracks the outcomes of its CME courses, and publishes these to share with the medical community. […]
PlatformQ Health is presenting an outcomes poster at the American Society of Retina Specialists 39th Annual Scientific Meeting on the impact of targeted online education. […]
PlatformQ Health and the American Society for Preventive Cardiology launched a virtual CME program and its outcomes were accepted as a publication of a poster at the Heart Failure Society of America Annual Scientific Meeting 2021. […]
PlatformQ Health, Parent Project Muscular Dystrophy, and the National Organization of Rare Disorders (NORD) produced a live, 60-minute CME session featuring a neurologist, pulmonologist, genetic counselor, and a patient advocate. […]
In collaboration with our partner, LUGPA, we produced two CME programs that had outcomes accepted at the 2021 ASCO Quality Care Symposium. […]
Some of the most important outcomes from the two-part activity highlight clinician barriers to practice in treating HER2/HER3 Metastatic Breast Cancer. […]
PlatformQ Health received the Best in Class award at the Alliance For Continuing Education in the Health Professions 2021 Virtual Alliance Industry Summit for the outcomes poster, “Unearthing the impact of Urology education through in-depth, qualitative interviews.” […]
An e-poster presentation on CIU education for patients, caregivers and health care providers demonstrates the impact of how virtual tethered education can close educational gaps and improve patient experience. […]
Through survey-based evaluation, the poster authors identified educational gaps that will fuel the future learning objectives and topics covered in new and upcoming educational initiatives. […]
Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and highlights the recent research collaborations to address challenges and advances in new treatments. […]
Partners present findings from an outcome-centric joint educational initiative that showcases the impact rare disease education can have on improving health outcome. […]
Researcher, Wendy Turell, DrPH, Vice President of CME Outcomes and Analytics at PlatformQ Health Education sought to evaluate and address knowledge and competence gaps when using immunotherapies as treatment for patients with advanced Non-Small Lung Cancer (NSLCL). […]
We leveraged our videobridge technology to give faculty and experts a platform to share insights from the numerous posters accepted, sharing insights from our CME and patient/caregiver activities. […]
PlatformQ Health is excited to share an e-poster presentation that was accepted at the 2020 American Academy of Neurology Annual Meeting. […]
PlatformQ Health is thrilled to share two e-poster presentations that will be exhibited at the 80th Scientific Session of the American Diabetes Association (ADA). […]
PlatformQ Health is excited to share a scientific poster that showcases the results from the patient and caregiver online educational program, Positive Knowledge and Behavior Shift Following Video-Based Patient Education on Pancreatic Cancer. […]
PlatformQ Health is excited to share a poster that showcases the results from the continuing medical education (CME) program, CGRP Blockage: The Evolving Landscape of Migraine Therapy, that was accepted at the 2020 American Academy of Neurology (AAN) Annual Meeting. […]
PlatformQ Health is excited to share results from an HCP and patient education initiative that were to be presented as two uniquely focused poster presentations at the American Academy of Allergy, Asthma and Immunology’s Annual Meeting and the American Academy of Dermatology’s 2020 Annual Meeting, respectively. […]
PlatformQ Health is excited to share a poster presentation that was accepted at the Oncology Nursing Society’s 45th Annual Congress, that shares insights from three online CME programs addressing nursing care for pediatric patients with high-risk neuroblastoma. […]
PlatformQ Health will present a poster session at the 2019 ASH Annual Meeting sharing insights from recent CME and patient education activities on Follicular Lymphoma. […]
PlatformQ Health is pleased to be able to share outcomes from a recent patient/caregiver program on clinical trials at the ASCO Quality Care Symposium in San Diego, CA this September. […]
PlatformQ Health is pleased to announce our education team will present a poster session at the 79th annual scientific session of the American Diabetes Association (ADA). […]
PlatformQ Health will be in Chicago for the 2019 ASCO Annual Meeting May 31 – June 4 and is pleased to have an abstract accepted for online publication for the 2019 meeting. […]
PlatformQ Health is pleased to announce our education team will present three poster sessions at this year’s Annual Meeting of the American Academy of Neurology (AAN), which will share insights from recent educational series in neurological diseases, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Lennox-Gastaut Syndrome, and Multiple Sclerosis (MS). […]
The 2018 ASCO Quality Care Symposium was held on September 28 and 29, 2018 in Phoenix, AZ, and PlatformQ Health was honored to present a poster session on the impact of online patient education for people with bladder cancer. […]
Our commitment to oncology practice and cancer care makes ASCO 2018 one of the most exciting events for our team, because it gives us an opportunity to explain how we’re improving healthcare outcomes through trusted digital education for people with cancer. […]
Jeff Arnold, General Manager at PlatformQ Health, attended the latest meeting of the American Urological Association (AUA) in San Francisco. […]
PlatformQ Health was proud to present two posters – a traditional poster and an e-poster – at this year’s Annual Meeting of the American Academy of Neurology (AAN). Alongside VP of Education Jayne Chaplick, Senior Medical Director Anne Roc attended to present the posters, which focus on insights from previous PQH educational initiatives. […]
PlatformQ Health is pleased to announce the Health Education Journal, a peer reviewed journal focusing on the contributions that health education can make to personal and social well-being, health promotion and individual and public health, has published an article on a recent Platform Q Patient Education (PQPE) program for people with B-cell NHL. […]
PlatformQ Health will present a poster at the Alliance Industry Summit (AIS) 2018 “Best in Class Outcomes Awards” Monday, May 7, 2018 highlighting a series of diabetes programs for clinicians created in collaboration with the renowned Joslin Diabetes Center. […]
PlatformQ Health is pleased to announce our education team will present two poster sessions at the 2018 Annual Meeting of the American Academy of Neurology April 23 and 24 in Los Angeles, California. […]